Hypothetical $10,000 invested at their first disclosed trade date. · log scale
Hypothetical backtest based on disclosed trades. Past performance does not predict future results. Not investment advice.
| Ticker | Action | Description | Traded |
|---|---|---|---|
| AVXL | Sell | Anavex Life Sciences Corp. | Dec 12, 2022 |
| AROC | Buy | Archrock, Inc. | Dec 12, 2022 |
| ATHA | Buy | Athira Pharma, Inc. | Dec 12, 2022 |
| BAC | Sell | Bank of America Corporation | Dec 12, 2022 |
| BRK-B | Buy | Berkshire Hathaway Inc. New | Dec 12, 2022 |
| BLFS | Sell | BioLife Solutions, Inc. | Dec 12, 2022 |
| MNRL | Buy | Brigham Minerals, Inc. Class | Dec 12, 2022 |
| SAVA | Buy | Cassava Sciences, Inc. | Dec 12, 2022 |
| CVX | Sell | Chevron Corporation | Dec 12, 2022 |
| CHRD | Buy | Chord Energy Corporation | Dec 12, 2022 |
Christopher L. Jacobs is a United States Representative from NY affiliated with the Republican Party, serving in the US House of Representatives. Disclosed Capitol tracks 255 disclosed stock trades from Christopher L. Jacobs, filed under the STOCK Act. The portfolio compounds at 2.2% annualized — 3.5% below the S&P 500 benchmark over the same period, with a 53% win rate on individual trades. The full trade history, holdings, sector allocation, and risk metrics are below.
Christopher L. Jacobs (R-NY) has disclosed 255 trades under the STOCK Act; portfolio CAGR of 2.2% (-3.5% vs. the S&P 500); top tickers traded: SAVA, ATHA, BAC.
Full trade list with transaction dates, disclosure dates, tickers, and amount ranges is in the interactive table below.
Most-traded tickers: SAVA, ATHA, BAC. Sector allocation and portfolio weighting appear in the Holdings panel.
Annualized return: 2.2% CAGR, -3.5% alpha vs. the S&P 500. Detailed performance charts are in the Performance panel.
Christopher L. Jacobs's disclosed stock portfolio is valued at approximately $836K across 50 tracked positions. This reflects only publicly disclosed, exchange-traded securities from STOCK Act filings — it excludes real estate, private assets, cash, and liabilities, so it is a partial floor on Christopher L. Jacobs's total net worth, not a complete measure of it.